{
    "clinical_study": {
        "@rank": "87315", 
        "arm_group": [
            {
                "arm_group_label": "Gluten free diet", 
                "arm_group_type": "Experimental", 
                "description": "BMS patients following a GFD"
            }, 
            {
                "arm_group_label": "Normal Diet", 
                "arm_group_type": "Sham Comparator", 
                "description": "Patients with BMS maintaing a normal diet"
            }
        ], 
        "brief_summary": {
            "textblock": "Gluten free diet (GFD) is now being tested in patients affected by schizophrenia, autism and\n      multiple sclerosis, making GFD a possible therapeutic weapon not only for celiac disease or\n      gluten sensitivity. In this protocol we investigate the effect of GFD in patients affected\n      by burning mouth syndrome (BMS), a disease of unknown origin characterized by oral and\n      especially tongue burning sensation, deeply decreasing the quality of life of patients"
        }, 
        "brief_title": "Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Burning Mouth Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Burning Mouth Syndrome", 
                "Burns"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -Primary BMS\n\n        Exclusion Criteria:\n\n          -  Celiac Disease\n\n          -  Psychiatric Disorders\n\n          -  intestinal autoimmune diseases\n\n          -  Ongoing cancer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867151", 
            "org_study_id": "BMS2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Gluten free diet", 
                "intervention_name": "Gluten Free Diet", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Normal Diet", 
                "intervention_name": "Normal Diet", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Burning Mouth Syndrome", 
            "Gluten", 
            "Gluten Free Diet"
        ], 
        "lastchanged_date": "May 31, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Milano", 
                    "country": "Italy", 
                    "zip": "20122"
                }, 
                "name": "Fondazione IRCCS Ca' Granda"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effetto Della Dieta Priva di Glutine in Soggetti Con BMS", 
        "overall_contact": {
            "email": "dottorlucaelli@gmail.com", 
            "last_name": "Luca Elli, MD", 
            "phone": "00390255033384"
        }, 
        "overall_official": {
            "affiliation": "Fondazione IRCCS C\u00e0 Granda", 
            "last_name": "Luca Elli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "oral pain will be evaluated by means of visual analogue scales", 
            "measure": "oral pain", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867151"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", 
            "investigator_full_name": "Prof. Pier Mannuccio Mannucci", 
            "investigator_title": "Scientific Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "quality of life of patients with BMS will be evaluated by means of SF36 questionnaire", 
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "28 days"
        }, 
        "source": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}